CAPTRUST Financial Advisors’s Charles River Laboratories CRL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$822K Sell
5,416
-3,755
-41% -$570K ﹤0.01% 1453
2025
Q1
$1.38M Buy
9,171
+2,750
+43% +$414K ﹤0.01% 1105
2024
Q4
$1.19M Sell
6,421
-1,951
-23% -$360K ﹤0.01% 1152
2024
Q3
$1.65M Sell
8,372
-989
-11% -$195K ﹤0.01% 938
2024
Q2
$1.93M Buy
9,361
+830
+10% +$171K 0.01% 834
2024
Q1
$2.31M Sell
8,531
-2,419
-22% -$655K 0.01% 749
2023
Q4
$2.59M Buy
10,950
+1,778
+19% +$420K 0.01% 803
2023
Q3
$1.8M Buy
9,172
+5,227
+132% +$1.02M 0.01% 902
2023
Q2
$829K Sell
3,945
-718
-15% -$151K ﹤0.01% 1321
2023
Q1
$941K Sell
4,663
-264
-5% -$53.3K ﹤0.01% 1074
2022
Q4
$1.07M Buy
4,927
+1,175
+31% +$256K 0.01% 933
2022
Q3
$738K Buy
3,752
+280
+8% +$55.1K ﹤0.01% 1072
2022
Q2
$743K Buy
3,472
+524
+18% +$112K ﹤0.01% 974
2022
Q1
$837K Buy
2,948
+113
+4% +$32.1K 0.01% 923
2021
Q4
$1.07M Sell
2,835
-457
-14% -$172K 0.01% 790
2021
Q3
$1.36M Buy
3,292
+76
+2% +$31.4K 0.01% 630
2021
Q2
$1.19M Sell
3,216
-268
-8% -$99.2K 0.01% 654
2021
Q1
$1.01M Buy
3,484
+1,697
+95% +$492K 0.01% 696
2020
Q4
$446K Sell
1,787
-709
-28% -$177K 0.01% 875
2020
Q3
$575K Sell
2,496
-26
-1% -$5.99K 0.01% 677
2020
Q2
$443K Buy
2,522
+19
+0.8% +$3.34K 0.01% 749
2020
Q1
$299K Sell
2,503
-132
-5% -$15.8K 0.01% 727
2019
Q4
$406K Buy
2,635
+2,065
+362% +$318K 0.01% 756
2019
Q3
$75K Sell
570
-7
-1% -$921 ﹤0.01% 863
2019
Q2
$82K Sell
577
-9
-2% -$1.28K ﹤0.01% 817
2019
Q1
$85K Sell
586
-26
-4% -$3.77K ﹤0.01% 743
2018
Q4
$69K Buy
612
+308
+101% +$34.7K ﹤0.01% 681
2018
Q3
$41K Sell
304
-86
-22% -$11.6K ﹤0.01% 811
2018
Q2
$44K Sell
390
-6
-2% -$677 ﹤0.01% 710
2018
Q1
$41K Buy
396
+184
+87% +$19.1K ﹤0.01% 655
2017
Q4
$23K Buy
+212
New +$23K ﹤0.01% 744